Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
申请人:Agouron Pharmaceuticals, Inc.
公开号:US20040023958A1
公开(公告)日:2004-02-05
Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.
1
式 I 的化合物是丙型肝炎病毒(HCV)RNA 依赖性 RNA 聚合酶(RdRp)抑制剂,可用于丙型肝炎病毒感染者的治疗和预防。
1